QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 19.74

-3.1%

Nov 10 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Randy Atkins who wrote (1435)	3/19/1998 11:23:00 AM
From: Robert Busse	Read Replies (1) of 1693

As most of us know, Qdel is developing a rapid test for the dx of influenza a + b thru a collaboration w/ Glaxo - which is funding the development costs of the test. Another company already has a flu test on the market which is a "one hour test" - I think Qdel's rapid test will be far superior to ZxmeTx's flu test and will only take a few minutes to perform ( this info from a call to the company.) Qdel's test is also being timed to coincide w/ the anticipated approval of Glaxo's flu treatment drug, Zanamivir, or GG 167 - now in phase III clinical trials. Also Glaxo will be promoting Qdel's tests as I understand it . Anyway, here is an interesting piece of news re the economics of testing for flu a + b. medicomint.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next